Compositions And Methods Of Diazeniumdiolate-based Prodrugs For Treating Cancer
Technology
E-261-2016
Patent ID
E-261-2016-0-US-04
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
10213445
Publication Number
US-2017-0333456-A1
Application Number
15/523,670
IC
NCI
Date Filed
Date Issued